Andrew Thomas Kirsch

Array ( [id] => 612446 [patent_doc_number] => 07147840 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-12 [patent_title] => 'Oxo-bacteriopyropheophorbide-a carboxylic acid and esters thereof' [patent_app_type] => utility [patent_app_number] => 11/066511 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 1558 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/147/07147840.pdf [firstpage_image] =>[orig_patent_app_number] => 11066511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7040552 [patent_doc_number] => 20050159413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/009631 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28644 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20050159413.pdf [firstpage_image] =>[orig_patent_app_number] => 11009631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991631 [patent_doc_number] => 20050090668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Preparation of 5-hydroxy-6-oxo-1,6-dihydropyrimidine compounds' [patent_app_type] => utility [patent_app_number] => 10/954752 [patent_app_country] => US [patent_app_date] => 2004-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10812 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090668.pdf [firstpage_image] =>[orig_patent_app_number] => 10954752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7255234 [patent_doc_number] => 20050075333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'CXCR3 antagonists' [patent_app_type] => utility [patent_app_number] => 10/946935 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 48739 [patent_no_of_claims] => 135 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075333.pdf [firstpage_image] =>[orig_patent_app_number] => 10946935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111768 [patent_doc_number] => 20050209224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds' [patent_app_type] => utility [patent_app_number] => 10/903870 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 70326 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209224.pdf [firstpage_image] =>[orig_patent_app_number] => 10903870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026783 [patent_doc_number] => 20050020592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Substituted heterocyclic compounds and methods of use' [patent_app_type] => utility [patent_app_number] => 10/897884 [patent_app_country] => US [patent_app_date] => 2004-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16246 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020592.pdf [firstpage_image] =>[orig_patent_app_number] => 10897884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7297276 [patent_doc_number] => 20040214797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Preserved pharmaceutical compositions comprising cyclodextrins' [patent_app_type] => new [patent_app_number] => 10/845671 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4489 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214797.pdf [firstpage_image] =>[orig_patent_app_number] => 10845671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 941315 [patent_doc_number] => 06969706 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-11-29 [patent_title] => 'Preserved pharmaceutical compositions comprising cyclodextrins' [patent_app_type] => utility [patent_app_number] => 10/844647 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4777 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/969/06969706.pdf [firstpage_image] =>[orig_patent_app_number] => 10844647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677180 [patent_doc_number] => 20040152646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Carbohydrate prodrugs of fluorooxindoles' [patent_app_type] => new [patent_app_number] => 10/762907 [patent_app_country] => US [patent_app_date] => 2004-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7701 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152646.pdf [firstpage_image] =>[orig_patent_app_number] => 10762907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7291867 [patent_doc_number] => 20040110936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'N-substituted pyrazole-O-glycoside derivatives and therapeutic agent for diabetes containing the same' [patent_app_type] => new [patent_app_number] => 10/692738 [patent_app_country] => US [patent_app_date] => 2003-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9430 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110936.pdf [firstpage_image] =>[orig_patent_app_number] => 10692738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677122 [patent_doc_number] => 20040152704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Bicyclic-substituted amines as histamine-3 receptor ligands' [patent_app_type] => new [patent_app_number] => 10/689735 [patent_app_country] => US [patent_app_date] => 2003-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 76809 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152704.pdf [firstpage_image] =>[orig_patent_app_number] => 10689735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225525 [patent_doc_number] => 20040072860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Piperazin-2-one amides as inhibitors of factor xa' [patent_app_type] => new [patent_app_number] => 10/381927 [patent_app_country] => US [patent_app_date] => 2003-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19068 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072860.pdf [firstpage_image] =>[orig_patent_app_number] => 10381927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7398046 [patent_doc_number] => 20040038973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Phthalimide derivatives as matrix metalloproteinase inhibitors' [patent_app_type] => new [patent_app_number] => 10/634717 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46244 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038973.pdf [firstpage_image] =>[orig_patent_app_number] => 10634717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7207559 [patent_doc_number] => 20040087604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Hetero-tricyclic compounds having substituted amino groups' [patent_app_type] => new [patent_app_number] => 10/250510 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52270 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087604.pdf [firstpage_image] =>[orig_patent_app_number] => 10250510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 758149 [patent_doc_number] => 07015225 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-03-21 [patent_title] => 'Anti-cancer agents and methods' [patent_app_type] => utility [patent_app_number] => 10/606084 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11317 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/015/07015225.pdf [firstpage_image] =>[orig_patent_app_number] => 10606084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367785 [patent_doc_number] => 20040006077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Thiazine and oxazine derivatives as MMP-13 inhibitors' [patent_app_type] => new [patent_app_number] => 10/602160 [patent_app_country] => US [patent_app_date] => 2003-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7985 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006077.pdf [firstpage_image] =>[orig_patent_app_number] => 10602160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7397962 [patent_doc_number] => 20040038969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Vanilloid receptor ligands and their use in treatments' [patent_app_type] => new [patent_app_number] => 10/445170 [patent_app_country] => US [patent_app_date] => 2003-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66087 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038969.pdf [firstpage_image] =>[orig_patent_app_number] => 10445170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6972300 [patent_doc_number] => 20050038010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Substituted heterocyclic compounds and methods of use' [patent_app_type] => utility [patent_app_number] => 10/438553 [patent_app_country] => US [patent_app_date] => 2003-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24108 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20050038010.pdf [firstpage_image] =>[orig_patent_app_number] => 10438553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7219391 [patent_doc_number] => 20040072138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Attenuation of ischemia/reperfusion injury' [patent_app_type] => new [patent_app_number] => 10/429231 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8953 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072138.pdf [firstpage_image] =>[orig_patent_app_number] => 10429231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474421 [patent_doc_number] => 20040097483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Benzimidazole derivatives useful as histamine H3 antagonists' [patent_app_type] => new [patent_app_number] => 10/417391 [patent_app_country] => US [patent_app_date] => 2003-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21504 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097483.pdf [firstpage_image] =>[orig_patent_app_number] => 10417391 [rel_patent_id] =>[rel_patent_doc_number] =>)